News
Value and Cancer: Journal of Cancer Policy Special Issue
25 January 2017
A special issue of the Journal of Cancer Policy entitled ‘Value and Cancer’ includes three papers authored by OHE researchers.
OHE Lunchtime Seminar with Andrea Manca: Economic Evaluation for Decision-making and the Value of Access to Individual Patient Data
16 January 2017
Professor Andrea Manca from the University of York will lead an OHE Lunchtime Seminar on 13th February 2017 on the topic of economic evaluation for decision-making…
Maynard Matters: A New Publication Covering Alan Maynard’s Contribution to Global Health Economics
13 January 2017
Maynard Matters is a new publication edited by Richard Cookson, Maria Goddard and Trevor Sheldon, published by University of York. The publication covers Alan’s contribution to…
New Publication: Assessing Evidence and Access Associated with NICE HTA Decisions Categorised as “Recommended in Line with Clinical Practice”
6 January 2017
A new OHE Research Paper assesses the nature of evidence used to reach HTA decisions which NICE have classified as “Recommended in Line with Clinical Practice”…
Comparing the Cancer-Specific EORTC-8D and the Generic EQ-5D-3L
4 January 2017
This early view paper published in Quality of Life Research compares a condition-specific preference based measure to a generic measure in a population of cancer patients.
Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico
4 January 2017
OHE has published a new report discussing a framework to help middle-income countries efficiently identify medicines for formulary inclusion. A second publication applies this framework to…
New OHE Research Paper: Extrapolation from Progression Free Survival to Overall Survival in Oncology
28 December 2016
The Office of Health Economics, in a research project funded by the Pharmaceutical Oncology Initiative (POI), has published a report entitled: Extrapolation from Progression Free Survival…
OHE at HESG Winter 2017: Meet the Team
22 December 2016
The HESG Winter 2017 Conference is to be held in Birmingham from 4th to 6th January 2017. Several members of the OHE team will be attending…
Recently Published: MCDA to Elicit Stakeholders’ Preferences: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma
20 December 2016
This paper uses MCDA to obtain preferences on decision criteria across three stakeholder groups (patients, clinicians and payers) in Italy and then uses these preferences to…